Log In
BCIQ
Print this Print this
 

PT 107

  Manage Alerts
Collapse Summary General Information
Company Pique Therapeutics Inc.
DescriptionAllogeneic tumor cell vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/07/2009

Undisclosed

0

Undisclosed

Get a free BioCentury trial today